Role of naringenin in protection against diabetic hyperalgesia and tactile allodynia in male Wistar rats

Journal of Physiology and Biochemistry

Volumn 70, Issue 4, 2014, Pages 997-1006

  Hasanein, Parisa ^a   Fazeli, Farzaneh ^a  

^a BU ALI SINA UNIVERSITY   (Iran)

Author keywords

Allodynia; Diabetes; Hyperalgesia; Hyperglycemia; Pain; Rats

Indexed keywords

GLUCOSE; NARINGENIN; PREGABALIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; ANTIDIABETIC AGENT; FLAVANONE DERIVATIVE; GLUCOSE BLOOD LEVEL;

ALLODYNIA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; FORMALIN TEST; GLUCOSE BLOOD LEVEL; HYPERALGESIA; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; NONHUMAN; PAIN; RAT; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; TAIL FLICK TEST; TREATMENT DURATION; WISTAR RAT; ANIMAL; BLOOD; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG SCREENING; ORAL DRUG ADMINISTRATION;

RATTUS; RATTUS NORVEGICUS;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; FLAVANONES; HYPERALGESIA; HYPOGLYCEMIC AGENTS; MALE; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84912014331     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-014-0369-5     Document Type: Article

References (37)

1. Abbott FV, Franklin KB, Westbrook RF (1995) The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60:91–102
2. Borradaile NM, de Dreu LE, Barrett PH, Huff MW (2002) Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters. J Lipid Res 43:1544–1554
3. Borradaile NM, de Dreu LE, Barrett PH, Behrsin CD, Huff MW (2003) Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP mediated microsomal triglyceride accumulation. Biochemistry 42:1283–1291
4. Calcutt NA (2004) Experimental models of painful diabetic neuropathy. J Neurol Sci 220:137–139
5. Calcutt NA, Freshwater JD, Mizisin AP (2004) Prevention of sensory disorders in diabetic Sprague–Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47:718–724
6. Chao CL, Weng CS, Chang NC, Lin JS, Kao ST, Ho FM (2010) Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia. Nutr Res 30:858–64
7. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63
8. Cheesman KH (1993) Lipid peroxidation in biological systems. In: Halliwell B, Aruoma OI (eds) DNA and free radicals. Ellis Horwood, London, pp 12–17
9. Coderre TJ, Fundytus ME, McKenna JE, Dalal S, Melzack R (1993) The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain 54:43–50
10. Courteix C, Eschalier A, Lavarenne J (1993) Streptozotocin-induced diabetic rats: behavioral evidence for a model of chronic pain. Pain 53:81–88
11. Craig WJ (1999) Health-promoting properties of common herbs. Am J Clin Nutr 70:S491–S499
12. Dobretsov M, Hastings SL, Romanovsky D, Stimers JR, Zhang JM (2003) Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res 960:174–183
13. Freshwater JD, Malmberg AB, Calcutt NA (2002) Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes 51:2249–55
14. Goldwasser J, Cohen PY, Yang E, Balaguer P, Yarmush ML, Nahmias Y (2010) Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha. PLoS One 5(8):e12399
15. Gupta M, Singh J, Sood S, Arora B (2003) Mechanism of antinociceptive effect of nimodipine in experimental diabetic neuropathic pain. Methods Find Exp Clin Pharmacol 25:49–52
16. Hasanein P, Soltani N (2009) Effects of the endocannabinoid transport inhibitors AM404 and UCM707 on diabetic neuropathy in rats. Clin Exp Pharmacol Physiol 36:1127–1131
17. Heo HJ, Kim DO, Shin SC, Kim MJ, Kim BG, Shin DH (2004) Effect of antioxidant flavanone, naringenin, from Citrus junos on neuroprotection. J Agric Food Chem 52:1520–1525
18. Heo HJ, Kim MJ, Lee JM, Choi SJ, Cho HY, Hong B, Kim HK, Kim E, Shin DH (2004) Naringenin from citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dement Geriatr Cogn Disord 17:151–157
19. Jain V, Jaggi AS, Singh N (2009) Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats. Pharmacol Res 59:385–92
20. Kaulaskar S, Bhutada P, Rahigude A, Jain D, Harle U (2012) Effects of naringenin on allodynia and hyperalgesia in rats with chronic constriction injury-induced neuropathic pain. Zhong Xi Yi Jie He Xue Bao 10:1482–9
21. Kitto KF, Haley JE, Wilcox GL (1992) Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett 148:1–5
22. Kumar A, Meena S, Kalonia H, Gupta A, Kumar P (2011) Effect of nitric oxide in protective effect of melatonin against chronic constriction sciatic nerve injury induced neuropathic pain in rats. Indian J Exp Biol 49:664–71
23. Lee JH, McCarty R (1992) Pain threshold in diabetic rats: effects of good versus poor diabetic control. Pain 50:231–236
24. Malcangio M, Tomlinson DR (1998) A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain 76:151–157
25. Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, Markle JM, Hegele RA, Huff MW (2009) Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 58:2198–2210
26. O’Connor AB, Dworkin RH (2009) Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 122:S22–S32
27. Ortiz-Andrade RR, Sánchez-Salgado JC, Navarrete-Vázquez G, Webster SP, Binnie M, García-Jiménez S, León-Rivera I, Cigarroa-Vázquez P, Villalobos-Molina R, Estrada-Soto S (2008) Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab 10:1097–1104
28. Park J-H, Lee J-W, Paik H-D (2010) Cytotoxic effects of 7-O-butyl naringenin on human breast cancer MCF-7 cells. Food Sci Biotechnol 19:717–724
29. Park HY, Kim GY, Choi YH (2012) Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases. Int J Mol Med 30:204–10
30. Rahigude A, Bhutada P, Kaulaskar S, Aswar M, Otari K (2012) Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neurosci 226:62–72
31. Rayidi S (2011) Effect of naringenin on carbohydrate metabolism in STZ-nicotinamide induced diabetic rats. Biomirror 2:1–9
32. Ribeiro IA, Rocha J, Sepodes B, Mota-Filipe Y, Ribeiro MH (2008) Effect of naringin enzymatic hydrolysis towards naringenin on the anti-inflammatory activity of both compounds. J Mol Catal B Enzym 52:13–18
33. Sotnikova R, Okruhlicova L, Vlkovicova J, Navarova J, Gajdacova B, Pivackova L, Fialova S, Krenek P (2013) Rosmarinic acid administration attenuates diabetes-induced vascular dysfunction of the rat aorta. J Pharm Pharmacol 65:713–23
34. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992) The formalin test: an evaluation of the method. Pain 51:5–17
35. Wilcox LJ, Borradaile NM, Huff MW (1999) Antiatherogenic properties of naringenin, a citrus flavonoid. Cardiovasc Drug Rev 17:160–178
36. Yamagishi S, Ogasawara S, Mizukami H, Yajima N, Wada R, Sugawara A, Yagihashi S (2008) Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats. J Neurochem 104:491–9
37. Zhao DD, Yu N, Li XK, Fang X, Mu QQ, Qin PJ, Ma Y, Mo FF, Zhang DW, Gao SH (2014) Antidiabetic and antioxidative effect of jiang tang xiao ke granule in high-fat diet and low-dose streptozotocin induced diabetic rats. Evid Based Complement Alternat Med 75192